Case of the week 41/2018


Use of CytoSorb in ischemic hepatic insufficiency due to hemorrhagic and septic shock
Dr. med. Christian Frey | Centre for Anesthesiology and Intensive Care Medicine, Hirslanden Clinic Aarau, Switzerland

This case study reports on a 73-year-old patient (known pre-existing conditions: untreated hypertension with repeated hypertensive derangements, cirrhotic left kidney due to renal artery stenosis), who presented at the hospital for elective pylorus-preserving pancreaticoduodenectomy due to pancreatic carcinoma..

The Therapy

An extracorporeal blood purification therapy to reduce excessive inflammation mediators

The Fields of Application

Treat septic shock & severe sepsis on ICU, prevent SIRS in cardiac surgery patients

The Studies

Current multi- and monocentric study projects in Europe and US, an international registry, case series

The Adsorber

A cutting edge bead technology turns CytoSorb into the only specifically approved extracorporeal cytokine adsorber

CytoSorb registry

Become part of the International CytoSorb registry!

For the first time treatment data, courses of treatment and results of a new treatment are systematically recorded according to highest scientific standards.